523 related articles for article (PubMed ID: 28163137)
1. Resistance to polymyxins in Gram-negative organisms.
Jeannot K; Bolard A; Plésiat P
Int J Antimicrob Agents; 2017 May; 49(5):526-535. PubMed ID: 28163137
[TBL] [Abstract][Full Text] [Related]
2. Preservation of Acquired Colistin Resistance in Gram-Negative Bacteria.
Lee JY; Choi MJ; Choi HJ; Ko KS
Antimicrob Agents Chemother; 2016 Jan; 60(1):609-12. PubMed ID: 26459897
[TBL] [Abstract][Full Text] [Related]
3. Polymyxins: Antimicrobial susceptibility concerns and therapeutic options.
Balaji V; Jeremiah SS; Baliga PR
Indian J Med Microbiol; 2011; 29(3):230-42. PubMed ID: 21860102
[TBL] [Abstract][Full Text] [Related]
4. Antibiotic-resistant gram-negative bacterial infections in patients with cancer.
Perez F; Adachi J; Bonomo RA
Clin Infect Dis; 2014 Nov; 59 Suppl 5(Suppl 5):S335-9. PubMed ID: 25352627
[TBL] [Abstract][Full Text] [Related]
5. Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era?
Falagas ME; Bliziotis IA
Int J Antimicrob Agents; 2007 Jun; 29(6):630-6. PubMed ID: 17306965
[TBL] [Abstract][Full Text] [Related]
6. Emergence of concurrent infections with colistin-resistant ESBL-positive Klebsiella pneumoniae and OXA-23-producing Acinetobacter baumannii sensitive to colistin only in a Romanian cardiac intensive care unit.
Timofte D; Dan M; Maciuca IE; Ciucu L; Dabija ER; Guguianu E; Panzaru CV
Eur J Clin Microbiol Infect Dis; 2015 Oct; 34(10):2069-74. PubMed ID: 26239064
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of the siderophore monosulfactam BAL30072 against contemporary Gram-negative pathogens from New York City, including multidrug-resistant isolates.
Landman D; Singh M; El-Imad B; Miller E; Win T; Quale J
Int J Antimicrob Agents; 2014 Jun; 43(6):527-32. PubMed ID: 24796217
[TBL] [Abstract][Full Text] [Related]
8. Resistance in nonfermenting gram-negative bacteria: multidrug resistance to the maximum.
McGowan JE
Am J Med; 2006 Jun; 119(6 Suppl 1):S29-36; discussion S62-70. PubMed ID: 16735148
[TBL] [Abstract][Full Text] [Related]
9. [Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study].
Gür D; Gülay Z; Akan OA; Aktaş Z; Kayacan CB; Cakici O; Eraç B; Gültekin M; Oğünç D; Söyletir G; Unal N; Uysal S
Mikrobiyol Bul; 2008 Oct; 42(4):537-44. PubMed ID: 19149074
[TBL] [Abstract][Full Text] [Related]
10. Emerging issues in the management of infections caused by multidrug-resistant gram-negative bacteria.
Rice LB
Cleve Clin J Med; 2007 Aug; 74 Suppl 4():S12-20. PubMed ID: 17847174
[TBL] [Abstract][Full Text] [Related]
11. [Evolution of susceptibility to antibiotics of Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumanii, in a University Hospital Center of Beirut between 2005 and 2009].
Hamouche E; Sarkis DK
Pathol Biol (Paris); 2012 Jun; 60(3):e15-20. PubMed ID: 21719212
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria.
Li J; Nation RL; Milne RW; Turnidge JD; Coulthard K
Int J Antimicrob Agents; 2005 Jan; 25(1):11-25. PubMed ID: 15620821
[TBL] [Abstract][Full Text] [Related]
13. Carbapenem and multidrug resistance in Gram-negative bacteria in a single centre in Italy: considerations on in vitro assay of active drugs.
Mezzatesta ML; Caio C; Gona F; Cormaci R; Salerno I; Zingali T; Denaro C; Gennaro M; Quattrone C; Stefani S
Int J Antimicrob Agents; 2014 Aug; 44(2):112-6. PubMed ID: 25059444
[TBL] [Abstract][Full Text] [Related]
14. Multidrug resistance among gram-negative pathogens that caused healthcare-associated infections reported to the National Healthcare Safety Network, 2006-2008.
Kallen AJ; Hidron AI; Patel J; Srinivasan A
Infect Control Hosp Epidemiol; 2010 May; 31(5):528-31. PubMed ID: 20334552
[TBL] [Abstract][Full Text] [Related]
15. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections.
Falagas ME; Kasiakou SK
Clin Infect Dis; 2005 May; 40(9):1333-41. PubMed ID: 15825037
[TBL] [Abstract][Full Text] [Related]
16. Mutant prevention concentrations of four carbapenems against gram-negative rods.
Credito K; Kosowska-Shick K; Appelbaum PC
Antimicrob Agents Chemother; 2010 Jun; 54(6):2692-5. PubMed ID: 20308376
[TBL] [Abstract][Full Text] [Related]
17. In vitro double and triple bactericidal activities of doripenem, polymyxin B, and rifampin against multidrug-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli.
Urban C; Mariano N; Rahal JJ
Antimicrob Agents Chemother; 2010 Jun; 54(6):2732-4. PubMed ID: 20368401
[TBL] [Abstract][Full Text] [Related]
18. Mutant prevention concentrations of colistin for Acinetobacter baumannii, Pseudomonas aeruginosa and Klebsiella pneumoniae clinical isolates.
Choi MJ; Ko KS
J Antimicrob Chemother; 2014 Jan; 69(1):275-7. PubMed ID: 23997018
[No Abstract] [Full Text] [Related]
19. Conditional probability analysis of multidrug resistance in Gram-negative bacilli isolated from tertiary medical institutions in South Korea during 1999-2009.
Kim YH
J Microbiol; 2016 Jan; 54(1):50-56. PubMed ID: 26727902
[TBL] [Abstract][Full Text] [Related]
20.
Ito A; Sato T; Ota M; Takemura M; Nishikawa T; Toba S; Kohira N; Miyagawa S; Ishibashi N; Matsumoto S; Nakamura R; Tsuji M; Yamano Y
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29061741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
